overdose of semaglutide symptoms GLP-1 overdoses have been skyrocketing, with poison centers seeing a nearly 1500% increase in calls related to or side effects injectable weight-loss drugs since 2019, according to US National Poison Thinking Ozempic or Wegovy for

If I Overdose An overdose involves administering more than the prescribed dose (e.g., taking two 0.5 mg doses in one week or confusing pens)

Changes in cognition and mortality in relation to exercise in late life: a population based study

Serious Ozempic Side Effects Acute gallbladder disease Acute kidney injury Allergic reactions Diabetic retinopathy Gastroparesis Hypoglycemia (when used with insulin or sulfonylurea) Increased risk of thyroid tumors Pancreatitis Some people may develop immunity to Ozempic

The currently observed decreases in NT-pro-BNP following treatment with orforglipron (perhaps more convincingly in the obesity study, ~ 19% reduction at highest doses) further suggest a potential for cardiovascular benefit

Storage: Lyophilized: refrigerate at 28 C (35.646.4 F)

Medicare has historically excluded weight-loss drugs by statute, though the Medicare GLP-1 Bridge demonstration (announced for July 2026) is set to cover Wegovy and Zepbound for eligible Part D beneficiaries at a $50/month copay, with the longer-term BALANCE Model launching in Part D in January 2027